665 - Bankruptcy and Purdue Pharma

Published: Sept. 22, 2023, 10 a.m.

A major bankruptcy case of Purdue Pharma\u2014the makers of Oxycontin\u2014now sits with the Supreme Court. How did it get there, and what\u2019s at stake? Andy Dietderich, an expert in bankruptcy law and co-head of finance and restructuring at New York law firm Sullivan and Cromwell, talks with Dr. Josh Sharfstein about the case, the Sackler family\u2019s involvement, and what a SCOTUS decision could mean for future settlements.